HOPCo Partners with Humana to Expand Musculoskeletal Care in Arizona
Healthcare Outcomes Performance Company (HOPCo) has partnered with Humana to expand its musculoskeletal (MSK) population health program to eligible Humana members in Arizona, announced in a press release.
The collaboration will use HOPCo’s Integrated Care System (ICS) to coordinate MSK care across in-person, virtual, and hybrid settings. The system leverages digital engagement tools and analytics to align providers and patients with evidence-based best practices.
HOPCo’s platform integrates patient engagement technologies such as the myrecovery application and connects members with specialists through the HOPCo Specialty Care Network, which includes more than 230 MSK physicians statewide. The network is the only URAC-accredited MSK clinically integrated network in the U.S.
The company recently strengthened its digital capabilities through the acquisition of AI-powered health platform Caro Health, further supporting its goal of delivering data-driven, value-based care solutions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
HiRO and Differentia Biotech Sign MOU for AI Clinical Trial Simulation
Onos Health Raises $17 Million for Behavioral Health AI Platform
Hello Patient Acquires Converse Health to Add Back Office AI Agents
Konko AI Raises $6 Million for Patient Journey Platform
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
Daily AI Brief: the AI news that matters, in your inbox.